Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 12/11/2019
SIETES contiene 92833 citas

 
 
 1 a 20 de 188 siguiente >>
Presentar resultados
Seleccionar todas
1. Cita con resumen
2. Cita con resumen
Ludvigsson JF, Ström P, Lundholm C, Cnattingius S, Ekbom A, Órtqvist A, Feltelius N, Granath F, Stephansson O. Maternal vaccination against H1N1 influenza and offspring mortality: population based cohort study and sibling design. BMJ 2015;351:h5585. [Ref.ID 99695]
3. Cita con resumen
Dobson J, Whitley RJ, Pocock S, Monto AS. Oseltamivir treatment for influenza in adults: a meta-analysis of randomised controlled trials. Lancet 2015;385:1729-37. [Ref.ID 98765]
4. Cita con resumen
DiazGranados CA, Dunning AJ, Kimmel A, Kirby D, Treanor J, Collins AJ, Pollak R, Christoff J, Earl J, Landolfi V, Martin E, Gurunathan S, Nathan R, Greenberg DP, Tornieporth NG, Decker MD, Talbot HK. Efficacy of high-dose versus standard-dose influenza vaccine in older adults. N Engl J Med 2014;371:635-45. [Ref.ID 97881]
5.Tiene citas relacionadas Cita con resumen
Hu Y, Lu S, Song Z, Want W, Hao P, Li J, Zhang X, Yen H-L, Shi B, Li T, Guan W, Xu L, Liu Y, Wang S, Zhang XS, Tian D, Zhu Z, He J, Huang K, Chen H, Zheng L, Li X, Ping J, Kang B, Xi X, Zha L, Li Y, Zhang Z, Peiris M, Yuan Z. Association between adverse clinical outcome in human disease caused by novel influenza A H7N9 virus and sustained viral shedding and emergence of antiviral resistance. Lancet 2013;381:2273-9. [Ref.ID 95761]
6.Tiene citas relacionadas
Hay AJ, Hayden FG. Oseltamivir resistance during treatment of H7N9 infection. Lancet 2013;381:2230-2. [Ref.ID 95754]
7.
Osterholm MT, Ballering KS, Kelley NS. Major challenges in providing and effective and timely pandemic vaccine for influenza A(H7N9). JAMA 2013;309:2557-8. [Ref.ID 95728]
8.Tiene citas relacionadas
Wang Y. The H7N9 influenza virus in China - Changes since SARS. N Engl J Med 2013;368:2348-9. [Ref.ID 95696]
9.Tiene citas relacionadas
Morens DM, Taubenberger JK, Fauci AS. Pandemic influenza viruses - Hoping for the road not taken. N Engl J Med 2013;368:2345-8. [Ref.ID 95695]
10. Cita con resumen
Kuehn BM. CDC: use antivirals early, aggressively for H7N9 flu. JAMA 2013;309:2086. [Ref.ID 95461]
11. Cita con resumen
Anónimo. Fighting H5N1 avian flu. JAMA 2010;303:1245. [Ref.ID 88257]
12.Tiene citas relacionadas
13.Tiene citas relacionadas
Khazeni N, Hutton DW, Garber AM, Hupert N, Owens DK. Effectiveness and cost-effectiveness of vaccination against pandemic influenza (H1N1) 2009. Ann Intern Med 2009;151:829-39. [Ref.ID 87421]
14. Cita con resumen
Watts G. A/H1N1 influenza virus. The basics. BMJ 2009;339:368-9. [Ref.ID 86497]
15. Cita con resumen
Shinde V, Bridges CB, Uyeki TM, Shu B, Balish A, Xu X, Lindstrom S, Gubareva LV, Deyde V, Garten RJ, Harris M, Gerber S, Vagasky S, Smith F, Pascoe N, Martin K, Dufficy D, Ritger K, Conover C, Quinlisk P, Klimov A, Bresee JS, Finelli L. Triple-reassortant swine influenza A (H1) in humans in the United States, 2005-2009. N Engl J Med 2009;360:2616-25. [Ref.ID 86056]
16. Cita con resumen
Jack A. The problem with flu vaccines. BMJ 2009;338:1298-9. [Ref.ID 85941]
17.Enlace a cita original Cita con resumen
Coombes R. Influenza A/H1N1. Questions and answers. BMJ 2009;338:1104-5. [Ref.ID 85797]
18.
Coker R. Swine flu. BMJ 2009;338:1087-8. [Ref.ID 85795]
19. Cita con resumen
Novel Swine-Origin Influenza A (H1N1) Virus Investigation Team. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med 2009;360:2605-15. [Ref.ID 85760]
20.Tiene citas relacionadas Cita con resumen
Baden LR, Drazen JM, Kritek PA, Curfman GD, Morrissey S, Campion EW. H1N1 influenza A disease — Information for health professionals. N Engl J Med 2009;360:2637-44. [Ref.ID 85759]
Seleccionar todas
 
 1 a 20 de 188 siguiente >>